Compare RKLB & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKLB | VTR |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 48.0B |
| IPO Year | 2020 | 2005 |
| Metric | RKLB | VTR |
|---|---|---|
| Price | $52.81 | $86.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 23 |
| Target Price | ★ $102.26 | $100.86 |
| AVG Volume (30 Days) | ★ 16.4M | 2.4M |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.39% |
| EPS Growth | 2.63 | ★ 184.21 |
| EPS | N/A | ★ 0.26 |
| Revenue | $601,799,000.00 | ★ $5,833,980,000.00 |
| Revenue This Year | $59.29 | $19.88 |
| Revenue Next Year | $38.82 | $12.64 |
| P/E Ratio | ★ N/A | $334.65 |
| Revenue Growth | ★ 37.96 | 18.47 |
| 52 Week Low | $37.57 | $68.15 |
| 52 Week High | $150.85 | $101.60 |
| Indicator | RKLB | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 33.60 | 53.97 |
| Support Level | N/A | $84.56 |
| Resistance Level | $77.02 | $88.37 |
| Average True Range (ATR) | 3.29 | 1.81 |
| MACD | -1.43 | 0.66 |
| Stochastic Oscillator | 11.99 | 85.16 |
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, and rest of the world and earns key revenue from the United States.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.